Project - Sublingual Exenatide

Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity.

Until now, both drugs are only available by injection. With the BioLingus drug delivery technology, both products are developed as orally available products.